FibroGen, Inc. (NASDAQ: FGEN) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy and Investor
FibroGen, Inc. (FGEN) Q2 2022 Earnings Call Transcript
Categories
Health Care
Canopy Growth Corporation (WEED) Q1 2023 Earnings Call Transcript
Canopy Growth Corporation (TSE : WEED) Q1 2023 earnings call dated Aug. 05, 2022 Corporate Participants: Tyler Burns -- Director of Investor Relations David
Amgen Inc. (AMGN) Q2 2022 Earnings Call Transcript
Amgen Inc. (NASDAQ: AMGN) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Arvind Sood -- Vice President, Investor Relations Robert A. Bradway -- Chairman
ABIOMED, Inc. (ABMD) Q1 2023 Earnings Call Transcript
ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath -- Manager of Investor Relations Michael R. Minogue -- Chairman,
Cigna Corporation (CI) Q2 2022 Earnings Call Transcript
Cigna Corporation (NYSE: CI) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Ralph Giacobbe -- Senior Vice President and Head of Investor
Zoetis Inc. (ZTS) Q2 2022 Earnings Call Transcript
Zoetis Inc. (NYSE: ZTS) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Steven Frank -- Vice President of Investor Relation Kristin C.
Eli Lilly and Company (LLY) Earnings: 2Q22 Key Numbers
Eli Lilly and Company (NYSE: LLY) reported second quarter 2022 earnings results today. Worldwide revenue decreased 4% to $6.49 billion compared to the
Moderna, Inc. (MRNA) Q1 2022 Earnings Call Transcript
Moderna, Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head of Investor
Regeneron Pharmaceuticals Inc. (REGN) Q2 2022 Earnings Call Transcript
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q2 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor Relations Leonard
CVS Health Corporation (CVS) Q2 2022 Earnings: Key financials and quarterly highlights
CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today. Total revenues increased 11% year-over-year to $80.6 billion. Net income
Sage Therapeutics, Inc. (SAGE) Q2 2022 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ: SAGE) Q2 2022 earnings call dated Aug. 02, 2022 Corporate Participants: Helen Rubinstein -- Director of Investor Relations Barry Greene -- Chief
AbbVie (ABBV) Q2 2022 Earnings Call Transcript
AbbVie (NYSE: ABBV) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Head of Investor Relations Richard Gonzalez -- Chairman
ImmunoGen, Inc. (IMGN) Q2 2022 Earnings Call Transcript
ImmunoGen, Inc. (NASDAQ: IMGN) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Anabel Chan -- Head of Investor Relations Mark Enyedy -- President &
AstraZeneca PLC (AZN) Q2 2022 Earnings Call Transcript
AstraZeneca PLC (NYSE: AZN) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Andy Barnett -- Head of Investor Relations Pascal Soriot -- Executive Director
EssilorLuxottica (EL) Q2 2022 Earnings Call Transcript
EssilorLuxottica (PA: EL) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Francesco Milleri -- Chairman and Chief Executive Officer Paul du Saillant -- Deputy
ABBV Earnings: Highlights of AbbVie’s Q2 2022 financial results
Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) has reported double-digit growth in second-quarter adjusted earnings, reflecting an increase in revenues. The company also
Pfizer Inc. (PFE) Q2 2022 Earnings Call Transcript
Pfizer Inc. (NYSE: PFE) Q2 2022 earnings call dated Jul. 28, 2022 Corporate Participants: Christopher Stevo -- Senior Vice President and Chief Investor Relations
Tilray, Inc. (TLRY) Q4 2022 Earnings Call Transcript
Tilray, Inc. (NASDAQ: TLRY) Q4 2022 earnings conference call dated Jul. 28, 2022 Corporate Participants: Berrin Noorata -- Chief Corporate Affairs Officer Irwin David
Bristol Myers Squibb (BMY) Q2 2022 Earnings: Key financials and quarterly highlights
Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today. Total revenue grew 2% year-over-year to $11.9 billion. Net earnings
Pfizer (PFE) Q2 2022 Earnings: Key financials and quarterly highlights
Pfizer Inc. (NYSE: PFE) reported second quarter 2022 earnings results today. Total revenues increased 47% year-over-year to $27.7 billion. Reported net income
Humana Inc. (HUM) Q2 2022 Earnings Call Transcript
Humana Inc. (NYSE: HUM) Q2 2022 earnings call dated Jul. 27, 2022 Corporate Participants: Lisa Stoner -- Vice President, Investor Relations Bruce D. Broussard -- President